Literature DB >> 11111989

Liver transplantation in patients over 60 years of age.

K Bjøro1, K Höckerstedt, B G Ericzon, S Friman, A Hjortrup, S Keiding, E Schrumpf, F Duraj, M Olausson, H Mäkisalo, A Bergan, P Kirkegaard.   

Abstract

Liver transplantation was previously only offered to patients under 60 years of age. We have analyzed the outcome after acceptance on the waiting list and after liver transplantation of patients over 60 years old. A total of 150 patients over 60 years old were listed for a first liver transplantation during 1990-1998. The annual number increased throughout the period. Primary biliary cirrhosis, primary sclerosing cholangitis, and acute hepatic failure were the most frequent diagnoses. A total of 119 patients received a first liver allograft. The patient 1-year survival was 75% and 3-year survival 62%, which was not significantly lower (P = 0.21) than that of the younger patients. When correcting for year of transplantation, the survival was, however, moderately but significantly lower than among the younger patients. Survival among those > 65 years (n = 38) did not differ from that of patients 60-65 years of age (n = 81). We conclude that an increasing number of patients over 60 years old can be listed for liver transplantation and receive a liver allograft with highly satisfying results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111989     DOI: 10.1007/s001470050315

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  2 in total

1.  Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.

Authors:  Yaara Leibovici-Weissman; Eytan Mor; Moshe Leshno; Amir Shlomai
Journal:  Dig Dis Sci       Date:  2017-01-04       Impact factor: 3.199

2.  Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study.

Authors:  Hsiu-Pin Chen; Yung-Fong Tsai; Jr-Rung Lin; Fu-Chao Liu; Huang-Ping Yu
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.